Gut bacteria and minerals: a new hope for ulcerative colitis remission?
NCT ID NCT07758335
First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time
Summary
This trial is testing whether adding a Lactobacillus probiotic or a trace element supplement to standard ulcerative colitis treatment can help keep the disease in remission. About 132 adults with mild to moderate ulcerative colitis will be randomly assigned to one of three groups: standard care plus the probiotic, standard care plus the supplement, or standard care alone. The study will measure changes in disease activity and colon healing over six months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Lactobacillus acidophilus probiotic and a trace element supplement (zinc, chromium, selenium, copper, iodine, iron, magnesium, molybdenum)
- What this could lead to
- If adding probiotics or trace elements to standard treatment helps keep ulcerative colitis in remission, it could offer a simple, low-cost way to improve disease control and reduce flare-ups.
- What could go wrong
- This is a mid-sized trial, and the benefits are uncertain. Probiotics and supplements may not outperform standard care, and individual responses can vary. Safety is monitored, but digestive side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TO EVALUATE THE EFFICACY OF LACTOBACILLUS PROBIOTICS WHEN ADDED TO UC STANDARD OF CARE IN MAINTAINING REMISSION IN UC PATIENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NHTMRI(national hepatology and tropical medicine research institute)
RECRUITINGCairo, Egypt